Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and peripheral blood mononuclear cells

J. Voortman, C. Ceresa, E. Giovannetti, A. C. Laan, R. Honeywell, G. Giaccone, G. J. Peters

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)34-34
JournalAnnals of Oncology
Publication statusPublished - 2008

Cite this